Skip to main content

AVBCC Highlights

Each year, the AVBCC Educational Summit & Program draws key stakeholders from across the ever-changing oncology ecosystem to exchange knowledge and information with the goal of improving access, cost, and quality. Although these conversations cover a range of pressing topics, their focus remains squarely on creating value and solutions in oncology. We invite you to check out some of the highlights from past meetings!
New Patient-Centric Cancer Care Models
AVBCC
AVBCC Highlights
The traditional role of oncology physicians as providers who diagnose disease and provide treatment has evolved as healthcare has shifted from a purely clinical discipline to one where patient-centered care is the focus.

Read More
Community-Based Providers Focus on Optimal Delivery of Care Despite Ongoing Challenges
By Wayne Kuznar
AVBCC 2021 Summit
Articles
Community-based providers remain at the core of the oncology care delivery system. A panel moderated by Barbara McAneny, MD, Chief Executive Officer, New Mexico Oncology Hematology Consultants, Albuquerque, at the 11th Annual Summit of the Association for Value-Based Cancer Care in 2021 explored the road ahead for community practices in terms of balancing value and delivering optimal access to care for patients.

Read More
Exploring the Future of Genetic Therapies and Value-Based Care in Oncology
By Wayne Kuznar
AVBCC 2021 Summit
Articles
With better insights into the biology of cancer and other diseases, genetic medicine is entering “a whole new ballgame,” said Scott Gottlieb, MD, Former FDA Commissioner, during the keynote session at the 11th Annual Summit of the Association for Value-Based Cancer Care in 2021.

Read More
Oncology Pipeline Overview: Recent Approvals and Near-Term Drugs
By Wayne Kuznar
AVBCC 2021 Summit
Articles
Many innovative therapies in oncology have made it to market recently, with a wealth of agents that are currently on the verge of FDA approval.

Read More
Support Services for Patients with Cancer Must Go Beyond Simply Building a HUB
By Wayne Kuznar
AVBCC 2021 Summit
Articles
The success of oncology support services developed by pharmaceutical manufacturers depends on tailoring programs that meet the needs of their specific patient populations, said panelists at a roundtable discussion on patient centricity and connectivity in oncology support and HUB services.

Read More
The Current and Future State of Medically Integrated Pharmacy in Oncology
By William King
AVBCC 2021 Summit
Articles
t the 11th Annual Summit of the Association for Value-Based Cancer Care in 2021, a panel of experts, moderated by Michael Reff, RPh, MBA, Founder and Executive Director, National Community Oncology Dispensing Association (NCODA), Cazenovia, NY, discussed the current and future state of Medically Integrated Pharmacy (MIP) and the benefits of this approach in oncology.

Read More
Biosimilars and the Road Ahead
By Wayne Kuznar
AVBCC 2021 Summit
Articles
Currently, 31 biosimilar products have been approved by the FDA, 20 of which have been launched in the United States.

Read More
Reducing Racial Disparities in Cancer Care
By William King
AVBCC 2021 Summit
Articles
Reducing disparities in cancer care, including those affecting research and treatment, requires a better understanding of the history of racism, noted experts during a panel discussion at the 11th Annual Summit of the Association for Value-Based Cancer Care in 2021. The panel, which was moderated by Sybil Green, JD, RPh, MHA, Diversity and Inclusion Officer, American Society of Clinical Oncology, examined barriers to equitable care and potential solutions to remove these barriers.

Read More
The Impact of Telehealth on Quality, Access, and Cost in Cancer Care
By Wayne Kuznar
AVBCC 2021 Summit
Articles
The use of telehealth in the fee-for-service program surged by more than 4000% during the first 6 months of the COVID-19 pandemic.

Read More
Drug Price Reform with Value in Mind: Is It Possible?
By Wayne Kuznar
AVBCC 2021 Summit
Articles
Oncologic drug pricing is being transformed with greater value in mind. At the 11th Annual Summit of the Association for Value-Based Cancer Care in 2021, a panel led by moderator William McGivney, PhD, Managing Principal, McGivney Global Advisors, Wayne, PA, discussed innovation in drug pricing, how the current rebate system supports higher drug costs, balancing new interventions with profits, and the implications of drug price negotiations being considered in Congress.

Read More

Page 2 of 3